ARCHIVES

FDA Designates Zometa For Priority Review.

This article is from The Cancer Letter archive.

Vol. 27 No. 44 | November 30, 2001

Download PDF Visit The Full Archive

Related Articles

Oregon Center Launching $1 Billion Program To Identify Lethal Cancers Before They Kill

May 9, 2014

Phase III Study: Lymphoseek Superior to Vital Blue Dye

June 24, 2011

In Brief: Carter Transition Team Lists Prospects For HEW Secretary; Interferon Available

December 3, 1976

NCI Adds $25 Million to R01, P01 Grant Pool In Fiscal 1990

February 23, 1990

Joseph Cullen, Cancer Prevention Leader, Dead At 54

November 30, 1990

In Brief: Streamlining Of Contract Award Process Still Top Priority At NCI; Training Grants No Closer

January 10, 1975